Enfiera 500mg Injection contains rituximab, a monoclonal antibody used to treat blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases like rheumatoid arthritis and certain rare inflammatory conditions. It works by targeting specific immune (B) cells involved in disease progression, helping control abnormal cell growth and immune activity.
Enfiera 500mg Injection is administered as an intravenous (IV) infusion under the supervision of a qualified healthcare professional. The dosage and treatment schedule are tailored to the patient’s medical condition and response to therapy. Since the benefits may take time to appear, it is important to follow your doctor’s instructions and complete the full course of treatment.
Common side effects of Enfiera include headache, weakness, infections, itching, diarrhea, and changes in blood pressure. Serious infusion-related reactions may occur during or shortly after administration and require immediate medical attention. Inform your doctor about any existing medical conditions before starting treatment. This medicine is not recommended during pregnancy or breastfeeding, and regular blood tests are required to monitor safety during therapy.
Enfiera 500mg Injection contains rituximab, a monoclonal antibody that targets the CD20 antigen on B-lymphocytes, a type of white blood cell involved in immune function and certain cancers. It works by attaching to these B-cells and destroying them through multiple mechanisms, including activating the immune system to kill the marked cells, triggering the body’s complement system to break them down, and inducing programmed cell death (apoptosis). By eliminating abnormal or overactive B-cells, Enfiera helps effectively treat non-Hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune conditions such as rheumatoid arthritis, making it a key therapy in cancer and immune disorder management.
Side Effects of Enfiera 500mg Injection
Like all medications, Enfiera 500mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
Enfiera 500mg Injection is administered as an intravenous infusion under the supervision of a qualified healthcare professional. The dosage and treatment schedule vary depending on the indication, patient’s body surface area, and clinical condition. It may be used alone or in combination with chemotherapy for cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, or in defined regimens for autoimmune disorders like rheumatoid arthritis. The exact dosage and duration are determined by the prescribing physician.
Enfiera 500mg Injection (rituximab) is not recommended during breastfeeding. Rituximab may pass into breast milk and could harm the nursing infant. Breastfeeding should be avoided during treatment and for at least 6 months after the last dose. Patients are advised to consult their physician for further guidance before resuming breastfeeding.
There is no clear evidence on the interaction between rituximab and alcohol. However, patients are advised to consult their doctor before consuming alcohol during treatment.
Enfiera 500mg Injection may rarely cause serious lung problems, including pneumonitis or breathing difficulties. Patients with lung conditions should use it cautiously and report symptoms like cough, shortness of breath, or chest tightness to their doctor immediately.
Enfiera 500mg Injection may cause fatigue, dizziness, or other side effects that can affect alertness. Patients should avoid driving or operating machinery if they experience these symptoms.
Enfiera 500mg Injection should be avoided during pregnancy unless clearly needed. Rituximab may harm the unborn baby. Women of childbearing potential should use effective contraception during treatment and for 12 months after the last dose.
Enfiera 500mg Injection is used to treat blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases including rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris.
Enfiera is administered as an intravenous (IV) infusion by a qualified healthcare professional in a hospital or clinical setting.
No, Enfiera should not be used during an active or serious infection. Inform your doctor about any ongoing or past infections before starting treatment.
Common side effects include headache, weakness, fever, rash, diarrhea, dizziness, swelling, and infections. Most side effects are manageable with medical supervision.
Yes, serious risks may include severe infusion reactions, hepatitis B reactivation, low blood cell counts, and serious infections. Seek immediate medical attention if you notice unusual symptoms.
Live vaccines should be avoided during and after Enfiera treatment, as the medicine can weaken the immune system.
No, Enfiera is not recommended during pregnancy or breastfeeding. Effective contraception should be used during treatment and for 12 months after the last dose.
The treatment response varies by condition. Improvement may take several weeks or even months after starting Enfiera therapy.
Yes, regular blood tests are needed to monitor blood cell levels, liver function, and screen for infections such as hepatitis B.
No, do not stop Enfiera treatment without consulting your doctor. Stopping treatment suddenly may worsen your condition or reduce treatment effectiveness.
| Active ingredient | Rituximab |
| Pharmacologic class | Anti-CD20 monoclonal antibodies |
| Medication category | Antineoplastics Agent,(DMARDs) Disease-Modifying Antirheumatic Drugs. |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
